非甾体抗炎药相关性肠病的研究进展及诊治
Research Progress, Diagnosis and Treatment of Non-Steroidal Anti-Inflammatory Drugs-Associated Bowel Disease
摘要: 非甾体抗炎药(nonsteroidal anti-inflammmory drugs, NSAIDs)具有解热镇痛等作用，用于缓解各种关节疼痛、多种发热和心血管疾病。随着NSAIDs的广泛应用，不良反应报道逐渐增多，但关于NSAIDs对肠黏膜损伤的报道却极少，在1966年NSAID (吲哚美辛)引起的小肠损伤才首次发表。近年来，随着双气囊小肠镜(DBE)及视频胶囊内镜(VCE)技术的发展和提高，发现NSAIDs不仅对胃肠道黏膜有损伤，还对小肠黏膜同样有损害作用，但其损伤机制、防治措施尚不明确，需引起重视。因此，本文就非甾体抗炎药相关性肠病作一综述。
Abstract: Nonsteroidal anti-inflammatory drugs (NSAIDs) have antipyretic and analgesic effects and they are used to relieve various joint pain, fever and cardiovascular diseases. With the wide application of NSAIDs, the reports of adverse reactions have gradually increased, but the reports of NSAIDs on in-testinal mucosal injury are very few. In 1966, the small intestinal injury caused by NSAIDs (indo-methacin) was first published. In recent years, with the development and improvement of dou-ble-balloon enteroscopy (DBE) and video capsule endoscopy (VCE) technology, it has been found that NSAIDs not only damage the gastrointestinal mucosa, but also damage the intestinal mucosa. However, its damage mechanism and prevention and treatment measures are still unclear and need to be paid attention to. Therefore, this article reviews the non-steroidal anti-inflammatory drug-related bowel disease.
文章引用：刘丽, 杨永林. 非甾体抗炎药相关性肠病的研究进展及诊治[J]. 临床医学进展, 2023, 13(3): 3979-3985. https://doi.org/10.12677/ACM.2023.133571

参考文献

[1] 韩文鹏, 郭春林, 丁瑞峰, 等. 非甾体类消炎药相关性小肠损伤发病机制研究进展[J]. 包头医学院学报, 2012, 28(4): 123-125.
[2] Watanabe, T., Fujiwara, Y. and Chan, F.K.L. (2020) Current Knowledge on Non-Steroidal An-ti-Inflammatory Drug-Induced Small-Bowel Damage: A Comprehensive Review. Journal of Gastroenterology, 55, 481-495. [Google Scholar] [CrossRef] [PubMed]
[3] Matsui, H., Shimokawa, O., Kaneko, T., et al. (2011) The Path-ophysiology of Non-Steroidal Anti-Inflammatory Drug (NSAID)-Induced Mucosal Injuries in Stomach and Small Intes-tine. Journal of Clinical Biochemistry and Nutrition, 48, 107-111. [Google Scholar] [CrossRef] [PubMed]
[4] Masubuchi, Y., Nakayama, S. and Horie, T. (2002) Role of Mitochondrial Permeability Transition in Diclofenac-Induced Hepatocyte Injury in Rats. Hepatology, 35, 544-551. [Google Scholar] [CrossRef] [PubMed]
[5] Al-Nasser, I.A. (1999) Salicylate-Induced Kidney Mitochondrial Perme-Ability Transition Is Prevented by Cyclosporin A. Toxicology Letters, 105, 1-8. [Google Scholar] [CrossRef] 
[6] Trost, L.C. and Lemasters, J.J. (1996) The Mitochondrial Permeability Transition: A New Pathophysiological Mechanism for Reye’s Syndrome and Toxic Liver Injury. Journal of Pharmacology and Experimental Therapeutics, 278, 1000-1005.
[7] Scatena, R., Bottoni, P., Botta, G., et al. (2007) The Role of Mitochondria in Pharmacotoxicology: A Reevaluation of an Old, Newly Emerging Topic. American Journal of Physiology-Cell Physiology, 293, C12-C21. [Google Scholar] [CrossRef] [PubMed]
[8] Watanabe, T., Tanigawa, T., Nadatani, Y., et al. (2011) Mitochon-drial Disorders in NSAIDs-Induced Small Bowel Injury. Journal of Clinical Biochemistry and Nutrition, 48, 117-121. [Google Scholar] [CrossRef] [PubMed]
[9] LoGuidice, A., Wallace, B.D., Bendel, L., et al. (2012) Pharmacologic Tar-geting of Bacterial Beta-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice. Journal of Pharmacology and Experimental Therapeutics, 341, 447-454. [Google Scholar] [CrossRef] [PubMed]
[10] Maiden, L., Thjodleifsson, B., Seigal, A., et al. (2007) Long-Term Effects of Nonsteroidal Anti-Inflammatory Drugs and Cyclooxygenase-2 Selective Agents on the Small Bowel: A Cross-Sectional Capsule Enteroscopy Study. Clinical Gastroenterology and Hepatology, 5, 1040-1045. [Google Scholar] [CrossRef] [PubMed]
[11] Takeuchi, K., Tanaka, A., Kato, S., et al. (2010) Roles of COX In-hibition in Pathogenesis of NSAID-Induced Small Intestinal Damage. Clinica Chimica Acta, 411, 459-466. [Google Scholar] [CrossRef] [PubMed]
[12] Ishikawa, H. and Watanabe, S. (2011) Cattle Bile Aggravates Diclo-fenac Sodium-Induced Small Intestinal in Mice. Evidence-Based Complementary and Alternative Medicine, 6, 1-68. [Google Scholar] [CrossRef] [PubMed]
[13] Melrange, R., Gentry, C., O’Connell, C., et al. (1992) Antiinflammatory and Gastrointestinal Effects of Nabumetone or Its Active Metabolite, 6-Methoxy-2-Naphthylacetic Acid (6MNA). Diges-tive Diseases and Sciences, 37, 1847-1852. [Google Scholar] [CrossRef] 
[14] Lim, Y.J., Dial, E.J. and Lichtenberger, L.M. (2013) Advent of Novel Phosphatidylcholine-Associated Nonsteroidal Anti-Inflammatory Drugs with Improved Gastrointestinal Safety. Gut and Liver, 7, 7-15. [Google Scholar] [CrossRef] [PubMed]
[15] Jacob, M., Foster, R., Sigthorsson, G., et al. (2007) Role of Bile Path-ogenes Is of Indomethacin Induced Enterpathy. Archives of Toxicology, 81, 291-298. [Google Scholar] [CrossRef] [PubMed]
[16] Poltorak, A., He, X., Smirnova, I., et al. (1998) Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene. Science, 282, 2085-2088. [Google Scholar] [CrossRef] [PubMed]
[17] Shimazu, R., Akashi, S., Ogata, H., et al. (1999) MD-2, a Molecule That Confers Lipopolysaccharide Responsiveness on Toll-Like Receptor 4. Journal of Experimental Medicine, 189, 1777-1822. [Google Scholar] [CrossRef] [PubMed]
[18] Narimatsu, K., Higashiyama, M., Kurihara, C., et al. (2015) Toll-Like Receptor (TLR) 2 Agonists Ameliorate Indomethacin-Induced Murine Ileitis by Suppressing the TLR4 Signaling. Journal of Gastroenterology and Hepatology, 30, 1610-1617. [Google Scholar] [CrossRef] [PubMed]
[19] Srinivasan, A. and De Cruz, P. (2017) Review Article: A Practical Ap-proach to the Clinical Management of NSAID Enteropathy. Scandinavian Journal of Gastroenterology, 52, 941-947. [Google Scholar] [CrossRef] [PubMed]
[20] 唐雯, 张大宽. 非甾体消炎药物致小肠黏膜损伤的研究进展[J]. 医学综述, 2013, 19(17): 3117-3119.
[21] Flicek, K.T., Hara, A.K., Petris, G.D., et al. (2014) Diaphragm Disease of the Small Bowel: A Retrospective Review of CT Findings. American Journal of Roentgenology, 202, W140. [Google Scholar] [CrossRef] 
[22] Wallace, J.L. (2013) Mechanisms, Prevention and Clinical Implications of Nonsteroidal Anti-Inflammatory Drug Enteropathy. World Journal of Gastroenterology, 19, 1861-1876. [Google Scholar] [CrossRef] [PubMed]
[23] Frye, J.M., Hansel, S.L., Dolan, S.G., et al. (2015) NSAID Enter-opathy: Appearance at CT and MR Enterography in the Age of Multi-Modality Imaging and Treatment. Abdominal Im-aging, 40, 1011-1025. [Google Scholar] [CrossRef] [PubMed]
[24] Caunedo-Alvarez, A., Gómez-Rodríguez, B.J., Romero-Vázquez, J., et al. (2010) Macroscopic Small Bowel Mucosal Injury Caused by Chronic Nonsteroidal Anti-Inflammatory Drugs (NSAID) Use as Assessed by Capsule Endoscopy. Revista Espanola De Enfermedades Digestivas, 102, 80-85. [Google Scholar] [CrossRef] 
[25] Lang, J., Price, A., Levi, A., et al. (1988) Diaphragm Disease: Pathology of Disease of the Small Intestine Induced by Non-Steroidal Anti-Inflammatory Drugs. Journal of Clinical Pathology, 41, 516-526. [Google Scholar] [CrossRef] [PubMed]
[26] Chun, H.J., Tanabe, S., Choi, M.G. and Saurin, J.C. (2016) Current Sta-tus and Future Directions of Capsule Endoscopy. Gastroenterology Research and Practice, 2016, Article ID: 4159745. [Google Scholar] [CrossRef] [PubMed]
[27] Hale, M.F., Sidhu, R. and McAlindon, M.E. (2014) Capsule Endosco-py: Current Practice and Future Directions. World Journal of Gastroenterology, 20, 7752-7759. [Google Scholar] [CrossRef] [PubMed]
[28] 邹建平, 张建军, 马晓雁, 等. 埃索美拉唑联合马来酸伊索拉定治疗非甾体消炎药相关性小肠病变的试验研究[J]. 中国医药, 2015, 10(5): 671-675. [Google Scholar] [CrossRef] 
[29] Wallace, J.L., Syer, S., Denou, E., et al. (2011) Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis. Gastroenterology, 141, 1314-1322. [Google Scholar] [CrossRef] [PubMed]
[30] Zhang, S., Qing, Q., Bai, Y., et al. (2013) Re-bamipide Helps Defend against Nonsteroidal Anti-Inflammatory Drugs Induced Gastroenteropathy: A Systematic Re-view and Meta-Analysis. Digestive Diseases and Sciences, 58, 1991-2000. [Google Scholar] [CrossRef] [PubMed]
[31] Watanabe, T., Sugimori, S., Kameda, N., et al. (2008) Small Bowel Injury by Low-Dose Enteric-Coated Aspirin and Treatment with Misoprostol: A Pilot Study. Clinical Gastroen-terology and Hepatology, 6, 1279-1282. [Google Scholar] [CrossRef] [PubMed]
[32] Kyaw, M.H., Otani, K., Ching, J.Y.L., et al. (2018) Misoprostol Heals Small Bowel Ulcers in Aspirin Users with Small Bowel Bleeding. Gastroenterology, 155, 1090-1097.e1. [Google Scholar] [CrossRef] [PubMed]
[33] Monteros, M.J.M., Galdeano, C.M., Balcells, M.F., et al. (2021) Probiotic Lactobacilli as a Promising Strategy to Ameliorate Disorders Associated with Intestinal Inflammation Induced by a Non-Steroidal Anti-Inflammatory Drug. Scientific Reports, 11, Article No. 571. [Google Scholar] [CrossRef] [PubMed]

为你推荐